Материал агрегирован из первоисточника:
arXiv — cs.AI
Читать полностью в arXiv — cs.AIМатериал собран из открытых источников. Если размещение затрагивает ваши права → Удалить информацию
Заголовок на английскомSpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity
Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs. We introduce…
Кратко от AI: Главные тезисы
- Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs
- We introduce…
SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity
Похожие материалы
Судья отклонил иск сестры Сэма Альтмана о сексуальном насилии
Во вторник окружной судья США Закари Блюстоун отклонил иск, поданный Энн Альтман в прошлом году, утверждая, что ее брат, генеральный директор OpenAI Сэм Альтман, подвергал ее сексуальному насилию на протяжении всего ее детства. Как ранее сообщало The Guardian, судья написала, что за последний год Энн...
ENAnthropic pitches AI safety bill that may block a model if 50+ people could be killed
The proposed policy seems to offer protections against AI run amok but actually forbids federal agencies from blocking a model's release without the permission of a judge.
ENHugging Face CEO warns that Netflix’s OpenAI hack documentary isn’t accurate
Before you share the Netflix documentary "AI Gone Rogue" take note. Clem Delangue, Hugging Face's co-founder who is featured in the film, says it went "full doomer mode" and isn't accurate.
ENAnthropic’s cloud partnerships are getting messy
Anthropic is reportedly struggling to secure enough compute from cloud providers that increasingly view it as a competitor, even as its infrastructure spending balloons ahead of a planned November IPO.